The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment

被引:0
|
作者
宋宇航 [1 ]
机构
[1] Dept Hematol,PUMC & CAMS
关键词
D O I
暂无
中图分类号
R733.3 [骨髓肿瘤]; R692 [肾疾病];
学科分类号
摘要
Objective To investigate the causative factors of renal function in newly diagnosed multiple myeloma(MM) patients with renal inadequacy.Methods 181MM patients with renal impairment from August 2007 to October 2021 at Peking Union Medical College Hospital were recruited,whose baseline chronic kidney disease(CKD) stage was 3-5.Statistical analysis was performed based on laboratory tests,treatment regimens,hematological responses,and survival among various renal function efficacy groups.A logistic regression model was employed in multivariate analysis.Results A total of 181 patients were recruited,and 277 patients with CKD stages 1-2 were chosen as controls.The majority were chosen according to the BCD and VRD regimens.The progression-free survival(PFS)(14.0 months vs24.8 months,P <0.001) and overall survival(OS)(49.2 months vs 79.7 months,P <0.001) of patients with renal impairment was considerably shorter.
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [31] Experience in treatment of newly diagnosed multiple myeloma patients with renal failure required dialysis
    Semochkin, S.
    Zhelnova, E.
    Misyurina, E.
    Tolstykh, T.
    Arkhipova, N.
    Baryakh, E.
    Grishina, E.
    Karimova, E.
    Kochneva, O.
    Mavrina, E.
    Polyakov, Y.
    Yaskova, E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Renal recovery is a favorable prognostic marker in patients with newly-diagnosed multiple myeloma
    Badea, M.
    Badea, D.
    Genuche, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 202 - 203
  • [33] Reversibility of Renal Failure in Newly Diagnosed Patients with Multiple Myeloma and the Role of Novel Agents
    Roussou, Maria
    Kastritis, Efstathios
    Christoulas, Dimitrios
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Matsouka, Charis
    Mparmparoussi, Despina
    Grapsa, Irini
    Psimenou, Erasmia
    Gika, Dimitra
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD, 2009, 114 (22) : 394 - 395
  • [34] CORRELATION OF LABORATORY DATA FOR RENAL FUNCTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Suzuki, Kazuhito
    Yano, Shingo
    Shimada, Takaki
    Takahara, Shinobu
    Kasama, Kinuyo
    Machishima, Tomohito
    Inui, Yumiko
    Kawashima, Masaharu
    Usui, Noriko
    Aiba, Keisuke
    ANNALS OF ONCOLOGY, 2014, 25
  • [35] Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
    Gaffney, Kelly J.
    Bakos, Jonathan K.
    Velayati, Arash
    Davis, James A.
    Thurlapati, Aswani
    Weeda, Erin
    Maldonado, Andy
    Granger, Katelynn
    Butcher, Coleen
    Herrington, Taylor
    Smith, Deidra
    Green, Kimberly
    Hess, Brian T.
    Hashmi, Hamza
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 72 - 80
  • [36] Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trial
    Rana, Ritika
    Cockwell, Paul
    Drayson, Mark
    Cook, Mark
    Pratt, Guy
    Cairns, David A.
    Pawlyn, Charlotte
    Jackson, Graham
    Davies, Faith
    Morgan, Gareth
    Pinney, Jennifer Helen
    BLOOD ADVANCES, 2020, 4 (22) : 5836 - 5845
  • [37] Reversibility of Renal Insufficiency in Patients with Newly Diagnosed Multiple Myeloma and the Role of different induction Regimens
    Bao, Li
    Lu, Jin
    Huang, Xiaojun
    BLOOD, 2014, 124 (21)
  • [38] Superior myeloma response with bortezomib-based regimen in multiple myeloma patients with renal impairment
    Bao, Li
    Lu, Jin
    Wang, Shihua
    Huang, Xiaojun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6200 - 6209
  • [39] EFFECTS OF BORTEZOMIB ON RENAL IMPAIRMENT MULTIPLE MYELOMA PATIENTS
    Chen, W.
    Lu, J.
    Hou, J.
    HAEMATOLOGICA, 2013, 98 : 340 - 341
  • [40] Optimizing the Treatment of Patients With Multiple Myeloma and Renal Impairment
    Grzasko, Norbert
    Morawska, Marta
    Hus, Marek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (04): : 187 - 198